KIT and myeloproliferative neoplasm: Nearly all patients with KIT D816V-mutated myelodysplastic syndromes (MDS), MPN, or overlapping MDS/MPN exhibited concurrent SM, whereas 44% of patients with AML and KIT D816V showed evidence of SM at some point in their disease course [72].